1-hexanol has been researched along with Cancer of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, C; Liu, H; Pan, Z; Wang, H; Wang, L | 1 |
Caccuri, AM; Cianfriglia, M; Ciriolo, MR; Dupuis, ML; Federici, G; Filomeni, G; Forini, O; Pezzola, S; Turella, P | 1 |
2 other study(ies) available for 1-hexanol and Cancer of Lung
Article | Year |
---|---|
Investigation of volatile organic metabolites in lung cancer pleural effusions by solid-phase microextraction and gas chromatography/mass spectrometry.
Topics: Aged; Aged, 80 and over; Female; Gas Chromatography-Mass Spectrometry; Hexanols; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Solid Phase Microextraction; Volatile Organic Compounds | 2014 |
6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Glutathione; Glutathione Transferase; Hexanols; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Necrosis; Oxadiazoles; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Substrate Specificity | 2008 |